- Home
- MG vs DCTH Comparison
MG vs DCTH Comparison
Compare MG & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MG
- DCTH
- Stock Information
- Founded
- MG 1978
- DCTH 1988
- Country
- MG United States
- DCTH United States
- Employees
- MG N/A
- DCTH N/A
- Industry
- MG Military/Government/Technical
- DCTH Medical/Dental Instruments
- Sector
- MG Consumer Discretionary
- DCTH Health Care
- Exchange
- MG Nasdaq
- DCTH Nasdaq
- Market Cap
- MG 366.2M
- DCTH 305.2M
- IPO Year
- MG 2009
- DCTH N/A
- Fundamental
- Price
- MG $9.19
- DCTH $11.90
- Analyst Decision
- MG Hold
- DCTH Strong Buy
- Analyst Count
- MG 1
- DCTH 4
- Target Price
- MG $11.00
- DCTH $21.50
- AVG Volume (30 Days)
- MG 166.4K
- DCTH 363.4K
- Earning Date
- MG 10-30-2024
- DCTH 11-08-2024
- Dividend Yield
- MG N/A
- DCTH N/A
- EPS Growth
- MG N/A
- DCTH N/A
- EPS
- MG 0.36
- DCTH N/A
- Revenue
- MG $738,983,000.00
- DCTH $11,878,000.00
- Revenue This Year
- MG $8.56
- DCTH $1,562.76
- Revenue Next Year
- MG $3.97
- DCTH $117.72
- P/E Ratio
- MG $25.49
- DCTH N/A
- Revenue Growth
- MG 6.85
- DCTH 350.44
- 52 Week Low
- MG $5.84
- DCTH $2.25
- 52 Week High
- MG $12.44
- DCTH $11.75
- Technical
- Relative Strength Index (RSI)
- MG 36.53
- DCTH 73.49
- Support Level
- MG $8.26
- DCTH $10.11
- Resistance Level
- MG $9.64
- DCTH $11.24
- Average True Range (ATR)
- MG 0.50
- DCTH 0.57
- MACD
- MG -0.25
- DCTH 0.08
- Stochastic Oscillator
- MG 24.88
- DCTH 79.24
About MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.